Vir Biotechnology Inc (NASDAQ: VIR) kicked off on Monday, down -4.37% from the previous trading day, before settling in for the closing price of $4.58. Over the past 52 weeks, VIR has traded in a range of $4.16-$14.45.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -18.74% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 15.74%. With a float of $89.57 million, this company’s outstanding shares have now reached $138.89 million.
In an organization with 408 employees, it is important to assess its efficiency.
Vir Biotechnology Inc (VIR) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Vir Biotechnology Inc is 35.52%, while institutional ownership is 57.14%. The most recent insider transaction that took place on Aug 01 ’25, was worth 109,699. In this transaction Director of this company sold 22,000 shares at a rate of $4.99, taking the stock ownership to the 1,276,391 shares. Before that another transaction happened on Jul 15 ’25, when Company’s EVP and Chief Medical Officer sold 6,796 for $5.47, making the entire transaction worth $37,162. This insider now owns 108,204 shares in total.
Vir Biotechnology Inc (VIR) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -1.56 earnings per share (EPS), lower than consensus estimate (set at -1.08) by -0.48. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.71 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.74% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.54% during the next five years compared to -18.74% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Take a look at Vir Biotechnology Inc’s (VIR) current performance indicators. Last quarter, stock had a quick ratio of 7.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 32.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.01, a number that is poised to hit -0.84 in the next quarter and is forecasted to reach -2.87 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Let’s dig in a bit further. During the last 5-days, its volume was 1.02 million. That was inferior than the volume of 1.56 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 53.19%.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 9.32%, which indicates a significant decrease from 24.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.23 in the past 14 days, which was lower than the 0.30 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.11, while its 200-day Moving Average is $6.88. However, in the short run, Vir Biotechnology Inc’s stock first resistance to watch stands at $4.55. Second resistance stands at $4.72. The third major resistance level sits at $4.82. If the price goes on to break the first support level at $4.28, it is likely to go to the next support level at $4.18. Assuming the price breaks the second support level, the third support level stands at $4.01.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
The company with the Market Capitalisation of 608.47 million has total of 138,916K Shares Outstanding. Its annual sales at the moment are 74,210 K in contrast with the sum of -521,960 K annual income. Company’s last quarter sales were recorded 1,210 K and last quarter income was -110,960 K.
